Management of Endocarditis

  • Janek Manoj Senaratne
  • Sean van DiepenEmail author


Infective endocarditis most commonly affects patients with structural heart disease or select sociodemographic risk factors. The Modified Duke Criteria are recommended to establish a diagnosis of endocarditis. Medical treatment consists of early empiric broad spectrum antibiotics followed by therapy tailored to the individual organism’s sensitivity. Patients with complicated or medically refractory endocarditis may also require surgical intervention. This chapter focuses on the diagnosis, suggested antimicrobial therapy, and indications for emergent surgical intervention. Controversial aspects of management including timing of surgery, neuroimaging in infective endocarditis, and management of patients with cerebral embolic strokes are also reviewed.


Infective endocarditis Modified Duke criteria Echocardiography Antimicrobial therapy Cardiac surgery Embolic stroke Endocarditis prophylaxis 


  1. 1.
    Nishimura R, Otto C, Bonow R, Carabello B, Erwin J III, Guyton R, O’Gara P, Ruiz C, Skubas N, Sorajja P, Sundt T, Thomas J. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:e521–643.PubMedGoogle Scholar
  2. 2.
    Habib G, Lancelloti P, Antunes M, Bongiorni M, Casalta J, Del Zotti F, Dulgheru R, El Khoury G, Erba P, Iung B, Miro J, Mulder B, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Mas P, Vilacosta I, Zamorano J, ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association of Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefGoogle Scholar
  3. 3.
    Baddour L, Wilson W, Bayer A, Fowler V Jr, Tleyjeh I, Rybak M, Barsic B, Lockhart P, Gewitz M, Levison M, Bolger A, Steckelberg J, Baltimore R, Fink A, O’Gara P, Taubert K, on behalf of the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86.CrossRefGoogle Scholar
  4. 4.
    Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi J, Ruimy R, Vandenesch F. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81.CrossRefGoogle Scholar
  5. 5.
    Berlin J, Abrutyn E, Strom B, Kinman J, Levison M, Korzeniowski O, Feldoman R, Kaye D. Incidence of infective endocarditis in the Delaware Valley, 1988–1990. Am J Cardiol. 1995;76:933–6.CrossRefGoogle Scholar
  6. 6.
    van der Meer J, Thompson J, Valkenburg H, Michel M. Epidemiology of bacterial endocarditis in the Netherlands. 1. Patient characteristics. Arch Intern Med. 1992;152:1863–8.CrossRefGoogle Scholar
  7. 7.
    Griffin MR, Wilson WR, Edwards WD, O’Fallon WM, Kurland LT. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985;254:1199–202.CrossRefGoogle Scholar
  8. 8.
    McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82:681–8.CrossRefGoogle Scholar
  9. 9.
    Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE. Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. J Thorac Cardiovasc Surg. 1994;108:207–14.CrossRefGoogle Scholar
  10. 10.
    Fernandez-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis. 2008;47:1287–97.CrossRefGoogle Scholar
  11. 11.
    Hill EE, Herjgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J. 2007;28:196–203.CrossRefGoogle Scholar
  12. 12.
    Murdoch D, Corey G, Hoen B, Miro J, Fowler V Jr, Bayer A, Karchmer A, Olaison L, Pappas P, Moreillon P, Chambers S, Chu V, Falco V, Holland D, Jones P, Klein K, Raymond N, Read K, Tripodi M, Utili R, Wang A, Woods C, Cabell C. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.CrossRefGoogle Scholar
  13. 13.
    Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefGoogle Scholar
  14. 14.
    Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol. 1991;18:391–7.CrossRefGoogle Scholar
  15. 15.
    Evangelista A, Gonzalez-Alujas M. Echocardiography in infective endocarditis. Heart. 2004;90:614–7.CrossRefGoogle Scholar
  16. 16.
    Reynold HR, Jagen MA, Tunick PA, Kronzon I. Sensitivity of transthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr. 2003;16:67–70.CrossRefGoogle Scholar
  17. 17.
    Dodds G, Sexton D, Durack D, Bashore T, Corey G, Kisslo J. Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol. 1996;15:403–7.CrossRefGoogle Scholar
  18. 18.
    Vieira M, Grinberg M, Pomerantzeff P, Andrade J, Mansur A. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart. 2004;90:1020–4.CrossRefGoogle Scholar
  19. 19.
    Iversen K, Ihlemann N, Gill S, Madsen T, Elming H, Jensen K, Bruun N, Hofsten D, Fursted K, Christensen J, Schultz M, Klein C, Fosboll E, Rosenvinge F, Schonheyder H, Kober L, Torp-Pedersen C, Helweg-Larsen J, Tonder N, Moser C, Bundgaard H. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med. 2019;380(5):415–24. Scholar
  20. 20.
    Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368:1425–33.CrossRefGoogle Scholar
  21. 21.
    Kang D, Kim Y, Kim S, Sun BJ, Kim D, Yun S, Song J, Choo SJ, Chung C, Song J, Lee J, Sohn D. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466–73.CrossRefGoogle Scholar
  22. 22.
    Prendergast B, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121:1141–52.CrossRefGoogle Scholar
  23. 23.
    Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Hofer D, Poewe W, Laufer G, Muller L. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094–9.CrossRefGoogle Scholar
  24. 24.
    Jovin T, Chamorro A, Cobo E, de Miquel M, Molina C, Rovira A, Román L, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Castaño C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, Demchuk A, von Kummer R, Gallofré M, Dávalos A, REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296–306. Scholar
  25. 25.
    Campbell B, Mitchell P, Kleinig T, Dewey H, Churilov L, Yassi N, Yan B, Dowling R, Parsons M, Oxley T, Wu T, Brooks M, Simpson M, Miteff F, Levi C, Krause M, Harrington T, Faulder K, Steinfort B, Priglinger M, Ang T, Scroop R, Barber P, McGuinness B, Wijeratne T, Phan T, Chong W, Chandra R, Bladin C, Badve M, Rice H, de Villiers L, Ma H, Desmond P, Donnan G, Davis S, EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.CrossRefGoogle Scholar
  26. 26.
    Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, Lepage L, Laissy J, Wolff M, Leport C, IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) Study Group. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010;152:497–504.CrossRefGoogle Scholar
  27. 27.
    Chu V, Cabell C, Benjamin D Jr, Kuniholm E, Fowler V Jr, Engemann J, Sexton D, Corey G, Wang A. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109:1745–9.CrossRefGoogle Scholar
  28. 28.
    Barsic B, Dickerman S, Krajinovic V, Pappas P, Altclas J, Carosi G, Casabe JH, Chu VH, Delahaye F, Edathodu J, Fortes CQ, Olaison L, Pangercic A, Patel M, Rudez I, Tamin SS, Vincelk J, Bayer AS, Wang A. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis. 2013;56:209–17.CrossRefGoogle Scholar
  29. 29.
    Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745–55.CrossRefGoogle Scholar
  30. 30.
    Tam D, Yanagawa B, Verma S, Ruel M, Fremes S, Mazine A, Adams S, Friedrich J. Early versus late surgery for patients with endocarditis and neurological injury: a systematic review and meta-analysis. Can J Cardiol. 2018;34:1185–99.CrossRefGoogle Scholar
  31. 31.
    Zegdi R, Debieche M, Latremouille C, Lebied D, Chardigny C, Grinda JM, Chauvaud S, Deloche A, Carpentier A, Fabiani JN. Long-term results of mitral valve repair in active endocarditis. Circulation. 2005;111:2532–6.CrossRefGoogle Scholar
  32. 32.
    Iung B, Rousseau-Paziaud J, Cormier B, Garbarz E, Fondard O, Brochet E, Acar C, Couetil JP, Hvass U, Vahanian A. Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol. 2004;43:386–92.CrossRefGoogle Scholar
  33. 33.
    Delay D, Pellerin M, Carrier M, Marchand R, Auger P, Perrault LP, Hebert Y, Cartier R, Page P, Pelletier LC. Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis. Ann Thorac Surg. 2000;70:1219–23.CrossRefGoogle Scholar
  34. 34.
    Feringa H, Shaw L, Poldermans D, Hoeks S, van der Wall E, Dion R, Bax J. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg. 2007;83:564–70.CrossRefGoogle Scholar
  35. 35.
    Johansen J, Jørgensen O, Møller M, Arnsbo P, Mortensen P, Nielsen J. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011;32:991–8.CrossRefGoogle Scholar
  36. 36.
    Uslan D, Sohail M, St Sauver J, Friedman P, Hayes D, Stoner S, Wilson W, Steckelberg J, Baddour L. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167:669–75.CrossRefGoogle Scholar
  37. 37.
    Sohail M, Uslan D, Khan A, Friedman P, Hayes D, Wilson W, Steckelberg J, Jenkins S, Baddour L. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83:46–53.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Cardiology, Department of MedicineUniversity of AlbertaEdmontonCanada
  2. 2.Department of Critical Care MedicineUniversity of AlbertaEdmontonCanada

Personalised recommendations